Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
100%(4 trials)

Phase Distribution

Ph phase_3
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
4(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 34 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_3

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide

NCT00560417
completedphase_3

Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes

NCT00487240
completedphase_3

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)

NCT00510952
completedphase_3

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

NCT00494013

Clinical Trials (4)

Showing 4 of 4 trials
NCT00560417Phase 3

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide

Completed
NCT00487240Phase 3

Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes

Completed
NCT00510952Phase 3

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)

Completed
NCT00494013Phase 3

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4